Elite Pharmaceuticals Inc (ELTP)

[NASDAQ2020]

17 Pathways to DollarLand

It only takes one or two to get us there
Working on 7 ADF opiods concurrently

1.) First ever generic ER ADF labeled Oxycodone ELI-201
2.) First ever generic Embeda®
3.) First ever generic Troxyca® waiting on comparator product
4.) A couple $50-100 million dollar ANDAs
5.) File First ever Abuse Deterrent generic of reformulated OxyContin® THIS quarter
6.) File Huge Blockbuster Undisclosed NDA
7.) Lauch All four SunGen generics ($3 Billion combined markets)
8.) Buyout/Acquisition
9.)BP Partnership for entire ADF line
10.)Uplisting to NASDAQ exchange 2018-19
11.) First ever ER opiod with out food restrictions
12.) Complete PH III trials for the first ever 24 hour
13.) Generic of Reformulated Opana ER
14.) First ADF opiod for Chinese Pain Market Elite being wined and dined by PuraCap/Humanwell on Valentines Day who control 60+% of Chinese market
15.) Canadian Approval of SequestOx-patents in place
16.) FDA accepts citizen petition urging the FDA to phase out oral prescription opioid analgesics that lack abuse-deterrent properties
17.) First ever Immediate Release ADF labeled opiod with ORAL AD Labeling on hold till FDA guidance recieved

ELTP